Linked Data API

Show Search Form

Search Results

100728
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Motor Neurone Disease more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much from the public purse has been spent on research into motor neurone disease in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211730 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman more like this
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100729
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Osteoporosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many (a) men under the age of 18, (b) women under the age of 18, (c) men between the ages of 18 and 60, (d) women between the ages of 18 and 60, (e) men over the age of 60 and (f) women over the age of 60 have been diagnosed with osteoporosis in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211737 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-10-30more like thismore than 2014-10-30
answer text <p>The provision of fracture liaison services (FLS) and falls services is a matter for local clinical commissioning groups (CCGs) and data on numbers is not collected centrally. NHS England advises that it is aware that provision of good FLS is not uniform across the country and is working with CCGs to support them to develop appropriate local services. It also advises that the FLS model recommended by the International Osteoporosis Foundation and the National Osteoporosis society is recognised as best practice and is being promoted. In addition to this, the guidance from the National Institute for Health and Care Excellence (NICE) ‘Falls: assessment and prevention of falls in older people’ sets out best practice for clinicians on the management of patients aged 65 and over who are susceptible to falls.</p><p> </p><p> </p><p> </p><p>Regarding the cost to the National Health Service of treating fractures attributable to osteoporosis, whilst programme budgeting data provides figures for annual NHS spend on musculoskeletal services in England, the cost of treating individual musculoskeletal conditions, such as osteoporosis or specific services such as FLS, is not available as part of this.</p><p> </p><p> </p><p> </p><p>Information concerning the number of people affected by osteoporosis in each of the last five years is not collected. NICE estimates that over 300,000 patients present with fragility fractures to hospitals in the United Kingdom each year.</p><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency North Norfolk more like this
answering member printed Norman Lamb more like this
grouped question UIN
211728 more like this
211736 more like this
211738 more like this
211740 more like this
question first answered
less than 2014-10-30T16:37:15.4253966Zmore like thismore than 2014-10-30T16:37:15.4253966Z
answering member
1439
label Biography information for Norman Lamb more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100730
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Osteoporosis: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to treat symptoms of osteoporosis in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211735 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman more like this
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100731
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much clinical commissioning groups in England spent on falls services in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211736 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-10-30more like thismore than 2014-10-30
answer text <p>The provision of fracture liaison services (FLS) and falls services is a matter for local clinical commissioning groups (CCGs) and data on numbers is not collected centrally. NHS England advises that it is aware that provision of good FLS is not uniform across the country and is working with CCGs to support them to develop appropriate local services. It also advises that the FLS model recommended by the International Osteoporosis Foundation and the National Osteoporosis society is recognised as best practice and is being promoted. In addition to this, the guidance from the National Institute for Health and Care Excellence (NICE) ‘Falls: assessment and prevention of falls in older people’ sets out best practice for clinicians on the management of patients aged 65 and over who are susceptible to falls.</p><p> </p><p> </p><p> </p><p>Regarding the cost to the National Health Service of treating fractures attributable to osteoporosis, whilst programme budgeting data provides figures for annual NHS spend on musculoskeletal services in England, the cost of treating individual musculoskeletal conditions, such as osteoporosis or specific services such as FLS, is not available as part of this.</p><p> </p><p> </p><p> </p><p>Information concerning the number of people affected by osteoporosis in each of the last five years is not collected. NICE estimates that over 300,000 patients present with fragility fractures to hospitals in the United Kingdom each year.</p><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency North Norfolk more like this
answering member printed Norman Lamb more like this
grouped question UIN
211728 more like this
211737 more like this
211738 more like this
211740 more like this
question first answered
less than 2014-10-30T16:37:15.2369445Zmore like thismore than 2014-10-30T16:37:15.2369445Z
answering member
1439
label Biography information for Norman Lamb more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100732
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Fractures more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how many clinical commissioning groups in England provide a fracture liaison service. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211738 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-10-30more like thismore than 2014-10-30
answer text <p>The provision of fracture liaison services (FLS) and falls services is a matter for local clinical commissioning groups (CCGs) and data on numbers is not collected centrally. NHS England advises that it is aware that provision of good FLS is not uniform across the country and is working with CCGs to support them to develop appropriate local services. It also advises that the FLS model recommended by the International Osteoporosis Foundation and the National Osteoporosis society is recognised as best practice and is being promoted. In addition to this, the guidance from the National Institute for Health and Care Excellence (NICE) ‘Falls: assessment and prevention of falls in older people’ sets out best practice for clinicians on the management of patients aged 65 and over who are susceptible to falls.</p><p> </p><p> </p><p> </p><p>Regarding the cost to the National Health Service of treating fractures attributable to osteoporosis, whilst programme budgeting data provides figures for annual NHS spend on musculoskeletal services in England, the cost of treating individual musculoskeletal conditions, such as osteoporosis or specific services such as FLS, is not available as part of this.</p><p> </p><p> </p><p> </p><p>Information concerning the number of people affected by osteoporosis in each of the last five years is not collected. NICE estimates that over 300,000 patients present with fragility fractures to hospitals in the United Kingdom each year.</p><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency North Norfolk more like this
answering member printed Norman Lamb more like this
grouped question UIN
211728 more like this
211736 more like this
211737 more like this
211740 more like this
question first answered
less than 2014-10-30T16:37:15.5348384Zmore like thismore than 2014-10-30T16:37:15.5348384Z
answering member
1439
label Biography information for Norman Lamb more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100733
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Fractures more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much clinical commissioning groups spent on fracture liaison services in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211740 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-10-30more like thismore than 2014-10-30
answer text <p>The provision of fracture liaison services (FLS) and falls services is a matter for local clinical commissioning groups (CCGs) and data on numbers is not collected centrally. NHS England advises that it is aware that provision of good FLS is not uniform across the country and is working with CCGs to support them to develop appropriate local services. It also advises that the FLS model recommended by the International Osteoporosis Foundation and the National Osteoporosis society is recognised as best practice and is being promoted. In addition to this, the guidance from the National Institute for Health and Care Excellence (NICE) ‘Falls: assessment and prevention of falls in older people’ sets out best practice for clinicians on the management of patients aged 65 and over who are susceptible to falls.</p><p> </p><p> </p><p> </p><p>Regarding the cost to the National Health Service of treating fractures attributable to osteoporosis, whilst programme budgeting data provides figures for annual NHS spend on musculoskeletal services in England, the cost of treating individual musculoskeletal conditions, such as osteoporosis or specific services such as FLS, is not available as part of this.</p><p> </p><p> </p><p> </p><p>Information concerning the number of people affected by osteoporosis in each of the last five years is not collected. NICE estimates that over 300,000 patients present with fragility fractures to hospitals in the United Kingdom each year.</p><p> </p><p> </p><p> </p><p> </p><p> </p>
answering member constituency North Norfolk more like this
answering member printed Norman Lamb more like this
grouped question UIN
211728 more like this
211736 more like this
211737 more like this
211738 more like this
question first answered
less than 2014-10-30T16:37:15.6753507Zmore like thismore than 2014-10-30T16:37:15.6753507Z
answering member
1439
label Biography information for Norman Lamb more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100734
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Osteoporosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much was spent on campaigns intended to raise public awareness of osteoporosis and its symptoms in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211739 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-10-30more like thismore than 2014-10-30
answer text <p>In the last five years there has been no budget allocated for specific osteoporosis national campaigns.</p><p> </p><p> </p><p> </p><p>Since April 2013 Public Health England’s marketing campaign investment approach has been to allocate budget against activity which has the greatest scope to deliver the key public health outcomes. This is based on lifestage rather than disease specific approach.</p><p> </p><p> </p><p> </p><p>More details of the 2014-2017 marketing campaign strategy can be found at</p><p> </p><p> </p><p> </p><p><a href="https://www.gov.uk/government/publications/public-health-england-marketing-strategy-2014-to-2017" target="_blank">https://www.gov.uk/government/publications/public-health-england-marketing-strategy-2014-to-2017</a></p><p> </p><p> </p><p> </p><p>There is a considerable amount of information about osteoporosis on NHS Choices website. However it is not possible to calculate the monetary value of this content.</p><p> </p><p> </p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2014-10-30T16:41:33.2849403Zmore like thismore than 2014-10-30T16:41:33.2849403Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100735
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Influenza: Vaccination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, pursuant to the Answer of 21 October 2014 to Question 210389, which groups who previously accessed free inoculations now no longer do so. more like this
tabling member constituency Blaydon more like this
tabling member printed
Mr David Anderson more like this
uin 211765 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-10-30more like thismore than 2014-10-30
answer text <p>Under the national seasonal flu vaccination programme, the following people continue to be offered the seasonal flu vaccination.</p><p> </p><p> </p><p> </p><p>- those aged 65 years and over;</p><p> </p><p>- those aged six months to under 65 in clinical risk groups;</p><p> </p><p>- pregnant women;</p><p> </p><p>- residents in long-stay care homes;</p><p> </p><p>- carers; and</p><p> </p><p>- health and social care workers.</p><p> </p><p> </p><p> </p><p>We have not withdrawn the seasonal flu vaccination from any patient group who was previously offered the vaccination.</p><p> </p><p> </p><p> </p><p>As outlined in my reply to the hon. Member I gave on 21 October 2014 to Question <a href="http://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2014-10-14/210389/" target="_blank">210389</a> the Government has commenced a programme to extend the seasonal flu vaccination to children aged two to less than 17 years.</p><p> </p><p> </p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2014-10-30T17:04:39.0523127Zmore like thismore than 2014-10-30T17:04:39.0523127Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1486
label Biography information for Mr David Anderson more like this
100736
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading NHS: Negligence more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what the number and value was of clinical negligence payments made by the NHS as a result of negligence committed by private healthcare providers in the latest period for which figures are available. more like this
tabling member constituency North Durham more like this
tabling member printed
Mr Kevan Jones more like this
uin 211786 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-10-30more like thismore than 2014-10-30
answer text <p>The number and value of clinical negligence payments made by the NHS Litigation Authority (NHS LA) as a result of negligence incurred by independent sector providers that are members of one of the NHS LA schemes, up to the 31 March 2014 is detailed in the following table:</p><p> </p><p> </p><p> </p><table><tbody><tr><td> </td><td><p>Number of Claims with Payments</p></td><td><p>Damages</p><p>Paid</p></td><td><p>Defence Costs</p><p>Paid</p></td><td><p>Claimant Costs</p><p>Paid</p></td><td><p>Total Paid</p></td></tr><tr><td><p>Private Sector</p></td><td><p>5</p></td><td><p>0</p></td><td><p>5,045</p></td><td><p>0</p></td><td><p>5,045</p></td></tr><tr><td><p>NHS Member</p></td><td><p>526</p></td><td><p>18,545,522</p></td><td><p>2,651,908</p></td><td><p>9,573,576</p></td><td><p>30,771,005</p></td></tr><tr><td><p>Department of Health</p></td><td><p>188</p></td><td><p>10,783,424</p></td><td><p>1,073,613</p></td><td><p>3,673,581</p></td><td><p>15,530,617</p></td></tr><tr><td><p>Total</p></td><td><p>719</p></td><td><p>29,328,945</p></td><td><p>3,730,565</p></td><td><p>13,247,157</p></td><td><p>46,306,667</p></td></tr></tbody></table><p> </p><p><strong> </strong></p><p> </p><p>Independent sector providers of NHS services have only been eligible to join the NHS LA’s clinical negligence scheme for trusts since April 2013. The likelihood of a claim being incurred, reported and settled in the same financial year is very low, hence the low values in the table, but private sectors members now contribute directly to the scheme for their own liabilities.</p><p> </p><p> </p><p> </p><p>In April 2013 arrangements were put in place so that sub-contractors would be covered by the NHS member of the scheme. This was to make the system less complex.</p><p> </p><p> </p><p> </p><p>Since April 2013, claims arising from the activities of independent sector providers have historically been funded by the NHS member organisations that have contracted with them.</p><p> </p><p> </p><p> </p><p>An element of these claims has been inherited and funded by the Department as a result of the abolition of primary care trusts and strategic health authorities on 1 April 2013.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p>
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
question first answered
less than 2014-10-30T16:33:48.2752613Zmore like thismore than 2014-10-30T16:33:48.2752613Z
answering member
3932
label Biography information for Dr Dan Poulter more like this
tabling member
1438
label Biography information for Mr Kevan Jones more like this
100737
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading NHS: Negligence more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what the number and value has been of clinical negligence payments made by the NHS as a result of negligence committed by Vanguard Healthcare. more like this
tabling member constituency North Durham more like this
tabling member printed
Mr Kevan Jones more like this
uin 211787 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-10-30more like thismore than 2014-10-30
answer text <p>The NHS Litigation Authority has no record of any claims payments made in connection with negligence incurred by Vanguard Healthcare, nor has it been notified by NHS members of its clinical negligence scheme for trusts of any claims where Vanguard Healthcare has been implicated.</p><p> </p> more like this
answering member constituency Central Suffolk and North Ipswich more like this
answering member printed Dr Daniel Poulter more like this
question first answered
less than 2014-10-30T16:31:19.9896641Zmore like thismore than 2014-10-30T16:31:19.9896641Z
answering member
3932
label Biography information for Dr Dan Poulter more like this
tabling member
1438
label Biography information for Mr Kevan Jones more like this